AstraZeneca withdraws COVID-19 vaccine from worldwide circulation – Washington Times

AstraZeneca is withdrawing its COVID-19 vaccine from worldwide circulation and marketing authorizations.

The British-Swedish company recently acknowledged side effects such as blood clots and low platelet counts in court papers, Reuters news agency reported Tuesday.

But AstraZeneca said in a statement that the slipping COVID-19 market has become saturated with newer vaccines, hurting Vaxzevrias sales.

As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines, the company said. Vaxzevria is no longer being manufactured or supplied, Reuters reported.

The multinational companys application to withdraw Vaxzevria was made March 5 and took effect Tuesday, according to the first reports on the matter from the Telegraph.

For more information, visit The Washington Times COVID-19 resource page.

Read more:

AstraZeneca withdraws COVID-19 vaccine from worldwide circulation - Washington Times

Related Posts
Tags: